News
People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...
12h
News-Medical.Net on MSNExperimental cancer drug shows promise in boosting tuberculosis treatmentAn experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...
5h
24/7 Wall St. on MSNI Have $80 Million But Feel Like I’m Still Working for Someone Else, Will It Ever Change?The movie Limitless (2011) featured Bradley Cooper in his first dramatic starring role as Eddie Morra, a struggling writer ...
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...
NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...
2don MSN
Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...
4don MSN
The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of ...
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results